HC Wainwright Has Optimistic Outlook of ITOS Q2 Earnings
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Investment analysts at HC Wainwright boosted their Q2 2025 earnings estimates for shares of iTeos Therapeutics in a research report issued to clients and investors on Tuesday, April 29th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($1.17) per share for […]
